Cabio Biotech (Wuhan) Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 87.76 million compared to CNY 75.54 million a year ago. Revenue was CNY 87.76 million compared to CNY 75.54 million a year ago.

Net income was CNY 14.31 million compared to CNY 23.22 million a year ago. Basic earnings per share from continuing operations was CNY 0.0857 compared to CNY 0.1357 a year ago. Diluted earnings per share from continuing operations was CNY 0.0857 compared to CNY 0.1357 a year ago.